Ad
related to: AstraZeneca
Search results
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 6 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
AstraZeneca (LON:AZN) Rating Reiterated by JPMorgan Chase & Co.
ETF DAILY NEWS· 4 days agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research report issued to ...
European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Investing.com· 6 days agoEuropean stocks fall in Fed rate concerns; AstraZeneca lifts revenue target
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 6 days agoDive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of...
AstraZeneca Admits Covishield Vaccine Can Cause Rare Side Effects, What Is TTS?
Homenewshere.com· 5 days agoAstraZeneca has acknowledged that its Covid vaccine, Covishield, can cause a rare side effect called...
AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com
Investing.com· 6 days agoU.K.-listed shares in AstraZeneca (LON:AZN) rose in morning trading on Tuesday after the...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
AstraZeneca (LON:AZN) Earns “Buy” Rating from Shore Capital
ETF DAILY NEWS· 3 days agoShore Capital reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports ...
AstraZeneca to harness China's 'explosion' of innovation to boost cell therapy R&D
FierceBiotech· 6 days agoAstraZeneca’s growing presence in China will play a key role in the Big Pharma’s cell therapy...